Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.
AUTOR(ES)
Boivin, G
RESUMO
We determined the acyclovir (ACV) susceptibilities of herpes simplex virus (HSV) isolates (n = 18) recovered from solid organ transplant patients after antiviral prophylaxis with ACV or ganciclovir. All isolates tested were susceptible to ACV (50% inhibitory concentration, < 1 microM). A clinical review of patients with HSV disease showed that all improved with specific anti-HSV therapy, and no recurrences were reported.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=187669Documentos Relacionados
- Acyclovir prophylaxis for herpes simplex virus infection.
- Acyclovir prophylaxis for herpes simplex virus infection.
- Infections in solid-organ transplant recipients.
- Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus▿
- Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review
